News

The grant will allow the company to advance the restriction enzyme research and usage in epigenetic studies. NEB research director Dr. Bill Jack said the company couples its

SGX203 contains an active corticosteroid, beclomethasone 17,21-dipropionate (BDP), that targets local inflamed tissue. The oral two tablet delivery system used for immediate and delayed release is designed for

BioClinica will also be providing Imaging Core Lab (ICL) solutions, which use new technology to efficiently acquire, process, and read medical images, for TauRx Therapeutics’ upcoming Phase III

The new knowledge base, called PACT-F (Preclinical And Clinical Trials Knowledge Base on Bioavailability) combines the results and experiences of the last hundred years of drug research and

The new permit will enable the company to supply pharmaceutical and biopharmaceutical companies a cGMP-compliant regional storage and stocking option for tightly regulated ethanol products and will also

Operating loss for third quarter of 2012 was $5.53m compared to operating loss of $10.35m for the third quarter of 2011. The company reported a net loss of

The launch is part of its involvement with the European INNOVAge project, which aims to implement new policies for eco-independent living. The Hub is one of 14 ‘InnoHubs’

Under the acquisition, DiscoveRx will add BioSeek’s BioMAP drug screening platform to its drug discovery solutions portfolio which includes GPCR, Kinase, and NHR assay solutions and KINOMEscan technology.

Total revenues for third quarter of 2012 were $854,696 compared to $2.64m for the third quarter of 2011. The company reported a net loss attributable to the company